Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2012
10/18/2012WO2012142288A1 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012WO2012142255A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012WO2012142083A2 C1q/tnf-related protein 12 and compositions and methods of using same
10/18/2012WO2012140114A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
10/18/2012WO2012140020A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012WO2012139993A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/18/2012WO2012139775A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor rar-related orphan receptor-gamma (rorgamma, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
10/18/2012WO2012112447A9 Histone deacetylase inhibitors and methods of use thereof
10/18/2012WO2012102560A3 Novel 4-0-methylhonokiol derivative and composition containing same as active ingredient for treatment of inflammatory diseases
10/18/2012US20120265712 Methods for Chronic Pain Management and Treatment using HCG
10/18/2012US20120265119 Transdermal Delivery of Medicinal Cetylated Fatty Esters using Phonophoresis or Iontophoresis
10/18/2012US20120265001 Composite magnetic nanoparticle drug delivery system
10/18/2012US20120264966 Sulfur-containing phospholipid derivatives
10/18/2012US20120264818 Topical Compositions with Cannabis Extracts
10/18/2012US20120264816 Sulfated Oxysterol and Oxysterol Sulfation by Hydroxysterol Sulfotransferase Promote Lipid Homeostasis and Liver Proliferation
10/18/2012US20120264809 RNAi-Mediated Inhibition of Histamine Receptor H1-Related Conditions
10/18/2012US20120264801 5-membered heterocycle-based p38 kinase inhibitors
10/18/2012US20120264798 Prodrugs of inhibitors of plasma kallikrein
10/18/2012US20120264790 Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
10/18/2012US20120264787 Respiratory Disease Treatment
10/18/2012US20120264762 Heterocyclic Compounds as CCR2 Antagonists
10/18/2012US20120264759 Benzyl substituted triazine derivatives and their therapeutical applications
10/18/2012US20120264755 Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase
10/18/2012US20120264749 Morpholine-spirocyclic piperidine amides as modulators of ion channels
10/18/2012US20120264746 Cell migration modulating compounds
10/18/2012US20120264740 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
10/18/2012US20120264730 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264729 Co-crystals and salts of ccr3-inhibitors
10/18/2012US20120264728 Amino-heteroaryl derivatives as hcn blockers
10/18/2012US20120264725 Substituted porphyrins
10/18/2012US20120264719 Dosage regimen of an s1p receptor modulator
10/18/2012US20120264717 Compounds, Compositions and Methods Comprising Oxadiazole Derivatives
10/18/2012US20120264716 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264715 Substituted bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012US20120264713 Use of docosatrienes, resolvins, and their stable analogs in the treatment of airway diseases and asthma
10/18/2012US20120264698 Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
10/18/2012US20120264682 Tissue protective peptides and uses thereof
10/18/2012US20120264676 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
10/18/2012US20120264675 Cmv gene products promote cancer stem cell growth
10/18/2012US20120263790 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/18/2012US20120263780 Carbohydrate Entrapped Active Agent Delivery Composition and Articles Using the Same
10/18/2012US20120263779 Biodegradable drug delivery system
10/18/2012US20120263765 Agents from cells
10/18/2012US20120263759 Coating Comprising An Elastin-Based Copolymer
10/18/2012US20120263747 Albumin-Fused Anti-Angiogenesis Peptides
10/18/2012US20120263736 Method for predicting and treating a sterile inflammation and discriminating between sterile and infective inflammation
10/18/2012US20120263733 Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inhibition of inflammation
10/18/2012US20120263731 HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS
10/18/2012US20120263730 Receptors of rspo2 and rspo3
10/18/2012US20120263729 Compositions and methods for treating cardiovascular disease
10/18/2012US20120263722 Dual Variable Domain Immunoglobulins and Uses Thereof
10/18/2012US20120263718 Blockade of tl1a-dr3 interactions to ameliorate t cell mediated disease pathology and antibodies thereof
10/18/2012US20120263714 Substituted halophenoxybenzamide derivatives
10/18/2012US20120263712 Pyrrolidine-1,2-dicarboxamide derivatives
10/18/2012US20120263708 Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
10/18/2012US20120263702 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis
10/18/2012US20120263695 Composition having strains of lactobacillus fermentum
10/18/2012US20120263687 Use of Mesenchymal Stem Cells for Treating Genetic Disease and Disorders
10/18/2012US20120263684 Novel methods for modulating inflammatory and/or immune responses
10/18/2012US20120263675 Bivalent diazo bicyclic smac
10/18/2012US20120263672 Biocompatible Adhesive Materials and Methods
10/18/2012US20120263653 Methods and systems for generating nanoparticles
10/18/2012US20120263651 Single Stranded DNA Aptamers Binding NF-kB/RelA
10/18/2012US20120263648 Rna nanoparticles and nanotubes
10/18/2012US20120263644 Treatment and diagnosis of inflammatory disorders and hiv
10/18/2012CA2833313A1 Phenyl bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833301A1 Substituted bicyclic methyl azetidines as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833255A1 Bicyclic methyl amine derivatives as sphingosine-1 phosphate receptors modulators
10/18/2012CA2833180A1 Novel piperidinyl monocarboxylic acids as s1p1 receptor agonists
10/18/2012CA2832704A1 Tri- and tetracyclic pyrazolo[3,4-b]pyridine compounds as antineoplastic agent
10/18/2012CA2832467A1 1,3 oxazines as bace1 and/or bace2 inhibitors
10/17/2012EP2511275A1 Novel piperidinyl monocarboxylic acids as S1P1 receptor agonists
10/17/2012EP2511272A1 Synthetic analogues of abscisic acid with anti-inflammatory and insulin release stimulation effects on human cells
10/17/2012EP2511263A1 Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
10/17/2012EP2510940A1 Use of cyr61 protein for preparing medicine
10/17/2012EP2510939A1 Anti-connexin peptide mimetics and therapeutic uses thereof
10/17/2012EP2510938A1 Anti-connexin antisense compounds and use thereof for treating vascular disorders
10/17/2012EP2510937A1 Anti-connexin compounds and use thereof in combination with transplant or grafting procedures
10/17/2012EP2509980A1 Heterocyclic compounds containing an indole core
10/17/2012EP2509975A1 Benzimidazole inhibitors of leukotriene production
10/17/2012EP2509964A1 Heterocyclic sulfonamide derivatives
10/17/2012EP2509943A1 2-methylene-19,26-nor-(20s)-l&-hydroxyvitamin d3
10/17/2012EP2509633A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
10/17/2012EP2509625A1 Aminoacyl trna synthetases for modulating inflammation
10/17/2012CN1948274B Verakanol derivative, preparation method and use thereof
10/17/2012CN1922171B Pyrimidine derivative
10/17/2012CN102741261A New aminoacid derivatives, their process of preparation and their therapeutical uses as inhibitors of oncogenic signals by the met family
10/17/2012CN102740892A Nanoparticle carrier systems based on poly(DL-lactic-co-glycolic acid) (PLGA) for photodynamic therapy (PDT)
10/17/2012CN102740890A Transdermal preparation containing basic anti-inflammatory agent
10/17/2012CN102740888A Antibodies to IL-6 and use there
10/17/2012CN102740866A Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
10/17/2012CN102740860A Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
10/17/2012CN102740854A Loxoprofen-containing pharmaceutical composition
10/17/2012CN102740848A Tetrahydro-pyran derivatives against neurological illnesses
10/17/2012CN102740844A Combination of droloxifene and clopidogrel
10/17/2012CN102732550A Expression of human s1CD80 protein in Pichia pastoris system
10/17/2012CN102731666A Method for extracting polysaccharide from cordyceps militaris medium
10/17/2012CN102731654A High affinity antibodies against hmgb1 and methods of use thereof
10/17/2012CN102731596A Flavonoid glycoside compound, its preparation method and application
10/17/2012CN102731522A Paeoniflorin compound with inhibitory activity against abnormal expression of cyclooxygenase-2, its preparation method and application
1 ... 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 ... 1272